Marketplace®
Every story is an economic story

Novartis moves away from mass-market drugs

New chief executive plots a fresh course for the pharmaceutical giant.

Drugmaker Novartis announced it’s cutting more than 2,000 jobs — most of them in Europe — as part of a global restructuring. The company plans to focus on producing and selling more innovative drugs, but these specified medicines require lots of research and carry higher price tags.

Click the audio player above to hear the full story.

Related Topics

Latest Episodes

View All Shows
  • Marketplace
    2 days ago
    25:28
  • Marketplace Morning Report
    2 days ago
    6:39
  • Marketplace Tech
    3 days ago
    13:02
  • This Is Uncomfortable
    4 days ago
    42:59
  • Million Bazillion
    13 days ago
    29:48
  • Make Me Smart
    5 months ago
    24:33